Israel In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2015

Summary

This report is an essential source for in-depth information and data relating to Israel In vitro diagnostic dvices market. It also offers detailed and comprehensive coverage of market revenue, distribution and company share information; and the latest news, financial deals and pipeline products information of each of the key sub-segments of the in vitro diagnostics market in Israel

Scope

• The report provides information on the Israeli vitro diagnostics market, broken down into detailed categories and segments including In Vitro Diagnostics Devices, Clinical Chemistry Test Reagents, Immunochemistry Test Reagents, Blood Test Reagents, Microbiology Test Reagents, Infectious Immunology Test Reagents, Genetic Test Reagents, Self Testing, and Instruments.

• Market shares of all the key competitors including F. Hoffmann-La Roche Ltd., Abbott Laboratories, Beckman Coulter, Inc., BioMerieux S.A., Ortho-Clinical Diagnostics Inc., and Siemens Medical Solutions, amongst others.

• Key pipeline products that are set to shape the market, broken down by sector.

• Information on the top medical equipment companies in the sector in the country covering business description, strategic analysis.

• Healthcare structure, regulatory environment, approval process, pricing trends and reimbursement.

• Product and brand updates, strategy changes, R&D projects, corporate expansions and contractions and regulatory changes.

• Key mergers and acquisitions, partnerships, private equity investments and IPOs.

• Customer, hospitals and physicians data.

Reasons to buy

• Gain a strong understanding of the in vitro diagnostics devices market in Israel.

• Evaluate and compare the attractiveness of the market in the country.

• Identify growth segments and opportunities in each industry sector within the country.

• Evaluate the pipeline of key products that will change the sector, and identify threats and opportunities before the products are launched in the country.

• Analyze the competitiveness of the market in the country and identify hotspots.

• Develop strategies based on the latest product, brand, expansion and research and development news in the country.

• Do deals with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the market in the country.

• Identify and analyze the strengths and weaknesses of the industry incumbents in the country.

1

1.1 List of Tables

1.2 List of Figures

2 Introduction

2.1 What Is This Report About?

3 Definitions of Markets Covered in This Report

3.1 In Vitro Diagnostics

3.2 Clinical Chemistry

3.2.1 Clinical Chemistry Rapid Tests & POC

3.2.2 Clinical Chemisty Analyzers

3.2.2.1 Automated Clinical Chemistry Analyzers

3.2.2.2 Semi-Automated Clinical Chemistry Analyzers

3.2.3 Electrolyte Chemistry Reagents

3.2.4 Enzyme Chemistry Reagents

3.2.5 Metabolite Chemistry Reagents

3.2.6 Urine Analysis

3.2.6.1 Urine Analyzer Reagents

3.2.6.2 Urine Analyzers

3.3 Genetic Testing

3.3.1 Acquired Gene or Chromosome Alterations

3.3.2 Inborn Gene or Chromosome Alterations

3.3.3 Other Genetic Tests

3.4 Haematology

3.4.1 Haematology Analyzers

3.4.2 Haematology Cell Counters

3.4.2.1 Differential Counters

3.4.2.2 Hemoglobinometers

3.4.3 Haematology Rapid Tests

3.4.3.1 Haemostasis Rapid Tests (Home Monitoring)

3.4.3.2 Rapid Haematology Tests (Point-Of-Care/Near Patient)

3.4.4 Haematology Reagents

3.4.4.1 Haematology Analyzer Reagents

3.4.4.2 Slide Stainers

3.4.5 Haemostasis

3.4.5.1 Coagulation Analyzers

3.4.5.2 Coagulation Factors

3.4.5.3 General Coagulation Tests

3.4.5.4 Platelet Factors

3.4.5.5 Special Coagulation Tests

3.4.6 Immunohaematology

3.4.6.1 ABO Typing

3.4.6.2 Antibody Detection

3.4.6.3 Rhesus Typing

3.5 Histology And Cytology

3.5.1 Cytology

3.5.1.1 Flow Cytometers

3.5.2 Histology

3.5.2.1 Monoclonal Antibodies

3.5.2.2 Tissue Typing Reagents

3.6 Immuno Chemistry

3.6.1 Disease Specific Immunochemistry

3.6.1.1 Auto-Immune Diseases

3.6.1.2 Cardiac Markers

3.6.1.3 Rheumatoid - Inflammatory Diseases Markers

3.6.1.4 Tumor markers

3.6.2 Drug Related Testing

3.6.2.1 Drugs of Abuse / Toxicology

3.6.2.2 Therapeutic Drug Monitoring

3.6.3 Endocrinology Tests

3.6.3.1 Fertility or Pregnancy Hormones

3.6.3.2 Individual and Specified Hormones

3.6.3.3 Thyroid Function Hormones

3.6.4 Immunochemistry Analyzers

3.6.4.1 Chemiluminescence Analyzers

3.6.4.2 ELISA Instruments

3.6.4.3 Immunofluorescence Analyzers

3.6.4.4 Radioimmunoassay Analyzers

3.6.5 Immunochemistry Rapid Tests

3.6.6 Organ Function Assays

3.6.7 Specific Proteins

3.7 Infectious Immunology

3.7.1 Bacteriology

3.7.2 Hepatitis Viruses